Glucagon-Like Peptide-1 Receptor Agonists

Lorenzo Leggio

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Baltimore, MD 21224, United States.; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, RI 02903, United States.; Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, United States.; Department of Neuroscience, Georgetown University Medical Center, Washington, DC 20057, United States.